LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
13.52
-0.02 (-0.15%)
At close: Jun 4, 2025, 4:00 PM
13.51
-0.01 (-0.07%)
After-hours: Jun 4, 2025, 4:04 PM EDT
LENSAR Market Cap
LENSAR has a market cap or net worth of $159.43 million as of June 4, 2025. Its market cap has increased by 239.53% in one year.
Market Cap
159.43M
Enterprise Value
136.71M
1-Year Change
239.53%
Ranking
Category
Stock Price
$13.52
Market Cap Chart
Since October 2, 2020, LENSAR's market cap has increased from $78.01M to $159.43M, an increase of 104.38%. That is a compound annual growth rate of 16.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2025 | 159.31M | 53.43% |
| Dec 31, 2024 | 103.84M | 163.00% |
| Dec 29, 2023 | 39.48M | 21.00% |
| Dec 30, 2022 | 32.63M | -50.28% |
| Dec 31, 2021 | 65.63M | -14.91% |
| Dec 31, 2020 | 77.13M | -1.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.23B |
| Johnson & Johnson | 373.45B |
| AbbVie | 328.75B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.41B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |